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Dear Editor-in-Chief,
We read with great interest the article by Abdi-Ali et al. 
entitled “IgA nephropathy with early kidney disease is 
associated with increased arterial stiffness and renin–angi-
otensin system activity” in the recent issue of Journal of the 
Renin–Angiotensin–Aldosterone System.1 In a study on 10 
normotensive IgA nephropathy (IgAN) subjects with early 
kidney disease and 10 gender- and blood pressure-matched 
healthy controls, blood pressure and arterial stiffness, 
expressed as pulse wave velocity and aortic augmentation 
index, at baseline and in response to 60 min of angiotensin 
II (AngII) infusion were measured. They found that IgAN 
patients had an increased aortic augmentation index and a 
trend towards increased circulating renin–angiotensin sys-
tem (RAS) components at baseline, compared with con-
trols.1 They also detected that IgAN was associated with 
reduced arterial sensitivity to angiotensin II (AngII) chal-
lenge. They concluded that IgAN is associated with 
increased arterial stiffness and decreased AngII responsive-
ness, a marker of increased RAS activity.1
We would like make some comments related to the vas-
cular pathology in IgAN. To evaluate the role of vascular 
disease in IgAN patients, we recently conducted a study on 
136 IgAN patients. We found a significant correlation 
between the scores of arteriolosclerosis and 
serum creatinine. This correlation for the intensity of intimal 
fibrosis of interlobular artery was also significantly positive. 
The correlation of arteriolosclerosis with proteinuria was 
also significantly positive. We concluded that the associa-
tion of vasculopathy with serum creatinine and amount of 
proteinuria further reinforces the role of vasculopathy in the 
aggravation of IgAN.2 There are very few studies that have 
reported to date on the significance of vasculopathy or its 
etiology in IgAN. It is, however, clear that the vascular dis-
orders in IgAN are accompanied by aggravation of renal 
failure and increased cardiovascular risk.3–5 However, the 
pathogenesis of the vascular disorders is still not completely 
understood. The study by Abdi-Ali et al.1 clearly shows the 
role of AngII in the aggravation of vasculopathy of IgAN. 
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Previously, El Karoui et al. showed that 53% of 128 IgAN 
patients had the morphologic lesions of thrombotic micro-
angiopathy (TMA).6 They concluded that morphologic 
lesions of TMA are frequent in IgAN.6 Interestingly, it has 
been speculated that AngII takes part in the initiation or pro-
gression of TMA.7–12 The findings of our study2 and the 
study conducted by El Karoui et al.6 further support the 
results of the present study. However, vasculopathy in IgAN 
requires more investigation in larger studies.
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